ethyl (E)-3-(2-methoxy-4-nitrophenyl)acrylate | 1202164-00-8

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: ethyl (E)-3-(2-methoxy-4-nitrophenyl)acrylate
• 英文别名: ethyl (E)-3-(2-methoxy-4-nitrophenyl)prop-2-enoate
• CAS: 1202164-00-8
• 化学式: C₁₂H₁₃NO₅
• 分子量: 251.239
• InChiKey: JVLKLPQRYKDVTD-FNORWQNLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  81.4
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  ethyl (E)-3-(2-methoxy-4-nitrophenyl)acrylate 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 反应 4.0h， 生成 ethyl 3-(4-amino-2-methoxyphenyl)propanoate
  参考文献：
  名称：

  Development of tryptase inhibitors derived from thalidomide

  摘要：

  A novel series of tryptase inhibitors with a N-phenylphthalimide skeleton structurally derived from thalidomide (1) has been developed. Structure-activity relationship studies led to a potent and selective tryptase inhibitor, 2-(4-cyanophenyl) isoindole-1,3-dione-5-yl 3-(2-aminopyridin-5-yl) propanoate (7), with the IC50 value of 78 nM. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.05.037
• 作为产物：
  描述：

  磷酰基乙酸三乙酯 、 2-甲氧基-4-硝基苯甲醛 在 potassium tert-butylate 作用下， 以 四氢呋喃 为溶剂， 反应 5.0h， 以95%的产率得到ethyl (E)-3-(2-methoxy-4-nitrophenyl)acrylate
  参考文献：
  名称：

  Development of tryptase inhibitors derived from thalidomide

  摘要：

  A novel series of tryptase inhibitors with a N-phenylphthalimide skeleton structurally derived from thalidomide (1) has been developed. Structure-activity relationship studies led to a potent and selective tryptase inhibitor, 2-(4-cyanophenyl) isoindole-1,3-dione-5-yl 3-(2-aminopyridin-5-yl) propanoate (7), with the IC50 value of 78 nM. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2010.05.037

文献信息

• Viral Polymerase Inhibitors
  申请人：Beaulieu Louis Pierre

  公开号：US20070142380A1

  公开（公告）日：2007-06-21

  An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein A, B, R 2 , R 3 , L, M 1 , M 2 , M 3 , M 4 , Y 1 , Y 0 , Z and Sp are as defined in claim 1 , or a salt thereof, as an inhibitor of HCV NS5B polymerase.

  一种化合物的同分异构体、对映异构体、非对映异构体或互变异构体，其化学式为I：其中A、B、R2、R3、L、M1、M2、M3、M4、Y1、Y0、Z和Sp如权利要求1所定义，或其盐，作为HCV NS5B聚合酶的抑制剂。
• US7223785B2
  申请人：——

  公开号：US7223785B2

  公开（公告）日：2007-05-29
• Development of tryptase inhibitors derived from thalidomide
  作者：Masashi Tetsuhashi、Minoru Ishikawa、Mariko Hashimoto、Yuichi Hashimoto、Hiroshi Aoyama

  DOI：10.1016/j.bmc.2010.05.037

  日期：2010.7

  A novel series of tryptase inhibitors with a N-phenylphthalimide skeleton structurally derived from thalidomide (1) has been developed. Structure-activity relationship studies led to a potent and selective tryptase inhibitor, 2-(4-cyanophenyl) isoindole-1,3-dione-5-yl 3-(2-aminopyridin-5-yl) propanoate (7), with the IC50 value of 78 nM. (C) 2010 Elsevier Ltd. All rights reserved.